China's Shanghai Pharma Aims At $2.13 Billion IPO In Final Guidance
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceuticals's final guideline for investors before its initial public offering and May 20 listing says it expects to raise $2.13 billion from the offering